Sunshine Biopharma Stock Forecast

Hold candidate since Jun 08, 2026

The Sunshine Biopharma, Inc. stock price fell by -1.22% on the last day (Monday, 8th Jun 2026) from $2.46 to $2.43. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 5.35% from a day low at $2.34 to a day high of $2.46. The price has fallen in 7 of the last 10 days and is down by -49.51% for this period. Volume has increased on the last day by 198 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 198 thousand shares were bought and sold for approximately $480.07 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -65.12% during the next 3 months and, with a 90% probability hold a price between $0.263 and $1.64 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

SBFM Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, June 01, 2026, and so far it has risen 1.67%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Sunshine Biopharma, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.52 and $6.87. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Sunshine Biopharma, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Sunshine Biopharma, Inc. stock

Sunshine Biopharma, Inc. finds support from accumulated volume at $2.39 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.125 between high and low, or 5.35%. For the last week, the stock has had daily average volatility of 11.07%.

Our recommended stop-loss: $2.31 (-4.92%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 5 days ago.)

Trading Expectations (SBFM) For The Upcoming Trading Day Of Tuesday 9th

For the upcoming trading day on Tuesday, 9th we expect Sunshine Biopharma, Inc. to open at $2.41, and during the day (based on 14 day Average True Range), to move between $1.83 and $3.03, which gives a possible trading interval of +/-$1.21 (+/-65.98%) up or down from last closing price. If Sunshine Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 65.98% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.39 (1.65%) than the resistance at $2.54 (4.57%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Sunshine Biopharma, Inc. stock A Buy?

Sunshine Biopharma, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Hold candidate.

Current score: 0.000 Hold/Accumulate Upgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on June 9, 2026 - $2.41 ( 0.89%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk